Validation Data on More Than 100 Patients published in Journal of Molecular Diagnostics CHICAGO, April 25, 2025 /PRNewswire/ -- Belay Diagnostics, a CLIA/CAP accredited laboratory focused on the ...
Fujirebio is launching a human cerebrospinal fluid (CSF) assay in its continuing efforts to detect Alzheimer’s ...
H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G pTau 217 CSF assay for the fully automated LUMIPULSE® G immunoassay analyzers. Th ...
For decades, diagnosis of brain cancer has been medicine’s most difficult and hazardous challenge. Simple imaging such as MRI scans may reveal a suspicious-looking lesion, but the only sure way to ...
As the world’s population ages, health experts are bracing for higher rates of age-related diseases, including Alzheimer’s. Finding new ways to diagnose the condition is more of a priority than ever, ...
Researchers at the new Center for Brain Health at UT Health San Antonio are studying midlife testing for early-onset dementia with blood-based biomarkers to see if they can detect disease activity up ...
Chemotherapy for pediatric acute lymphoblastic leukemia (ALL) induces rapid and durable alterations in cerebrospinal fluid (CSF) metabolism, and a lipid-rich CSF signature measured early in treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results